Radioiodine treatment of hyperthyroidism in patients with low thyroid iodine uptake

Nuclear Medicine Review

Volumn 8, Issue 1, 2005, Pages 28-32

  Ruchała, Marek ^a   Sowiński, Jerzy ^a   Dolata, Magdalena ^a   Junik, Roman ^b   Gembicki, Maciej ^a   Skiba, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

131 I therapy; Hyperthyroidism; Low iodine uptake

Indexed keywords

ANTITHYROID AGENT; IODINE; IODINE 131; LIOTHYRONINE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESPONSE; DRUG UPTAKE; ECHOGRAPHY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RADIOIMMUNOASSAY; RADIOISOTOPE THERAPY; REMISSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THYROID GLAND; TOXIC GOITER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GAMMA CAMERAS; GOITER, NODULAR; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROTROPIN; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 21444443181     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hamilton HG, Lawrence HH. Recent clinical developments in the therapeutic application of radio phosphorous and radioiodine. J Clin Invest 1942; 21: 642.
2. Horst W. Die therapie der hyperthyreosen mit radiojod. Strahlenther 1951; 85: 186-195.
3. Editorial. Optimisation of radioiodine therapy of thyreotoxicosis: what have we learned after 50 years? J Nucl Med. 1993; 34: 1638-1641.
4. Eckstein A et al. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol. 2003; 87: 773-776.
5. Willemsen UF, Knesewitsch P, Kreisig T, Pickardt CR, Kirsh CM. Functional results of radioiodine therapy with a 300-GY absorbed dose in Graves'disease. Eur J Nucl Med 1993; 20: 1051-1055.
6. Kendall-Taylor P, Keir MJ, Ross WM. Ablative radioiodine therapy for hyperthyroidism: longterm follow up study. Br Med. J 1984; 289: 361-363.
7. Scott GR, Forfar JC, Toft AD. Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131. Br Med J 1984; 289: 399-400.
8. Enrikkson E, Enrikkson K, Wahlbergh P. Treatment of hyperthyroidism with standard doses of radioiodine aimed at ablation. Acta Med Scand 1985; 217: 55-60.
9. William D Leslie, Linda Ward, Elizabeth A. Salamon et al. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003; 88: 978-983.
10. Douglas Howarth, Martin Epstein, Linda Lan et al. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Eur J Nucl Med 2001; 28: 1489-1495.
11. Gietka-Czernel M. Treatment of thyreotoxicosis with iodine. In: Zgliczyński S. Ed. Thyroid Diseases. Urban & Partner, Wrocław 1998: 219-334.
12. Nordyke RA, Gilbert FI. Optimal Iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991; 32: 411-416.
13. Bogazzi F, Bartalena L, Gasperi M et al. The various effects of amiodarone on thyroid function. Thyroid 2001; 11: 511-519.
14. Alexander EK, Reed Larsen P. High Dose 131-I Therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 2002; 87: 1073-1077.
15. Walter MA., Christ-Crain M, Eckard B et al. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Eur J Clin Invest 2004; 34: 365-370.
16. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest 1996; 26: 59-63.
17. Junik R, Oleksa R, Ruchała M, Pietz L, Sowiński J, Gembicki M. Evaluation of volume changes of thyroid gland measured ultrasonographically in patients with thyreotoxicosis treated with 131-I. Medical News 1997; 66,1: 89-94.
18. Pedersen-Bjergaard U, Kirkegaard G. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre. Eur J Nucl Med 1997; 137: 365-369.
19. Sowiński J. Evaluation of hypothalamus - hypophysis - thyroid axis in the course of radionuclide treatment of thyreotoxicosis. PHD thesis. Polish Endocrinology 1987; 38: Suppl.